Physician

Christopher C. Oh, M.D.

According to 2025 Medicare claims, Christopher Oh, M.D. (NPI: 1942208889) practices nuclear medicine in the Salinas, CA market, with the plurality of this provider's patient population coming from Monterey, CA. This provider's primary affiliated billing organization is SVMHS CLINICS (NPI: 1093158347; TIN: 352401992) and primary practice location at 93901-3901. Oh is affiliated with the Aledade 91 CA MSSP Basic E (ACO ID: A5193), participating under the MSSP model.

Oh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,211 traditional Medicare patients, billed 5,777 HCPCS/CPT codes, and received $304,411 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 8,884 prescription claims across 877 beneficiaries totaling $2,125,029 in drug costs, led by Vyndamax (Tafamidis). DME data shows 26 claims. Open Payments data shows 156 records totaling $3,647. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $444,098 to $2,125,029. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $10,404 and ending at $39,645.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,815	6,875	$433,948
2016	3,110	8,003	$463,427
2017	2,843	6,519	$282,417
2018	3,111	7,112	$317,456
2019	3,338	7,416	$307,368
2020	2,203	5,289	$273,418
2021	2,678	6,340	$353,054
2022	2,298	6,107	$335,182
2023	2,210	6,292	$354,522
2024	2,211	5,777	$304,411

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	452	4,055	$444,098
2016	489	4,492	$499,230
2017	528	5,106	$526,929
2018	615	5,873	$673,078
2019	643	6,497	$808,144
2020	662	6,807	$917,148
2021	710	7,244	$932,032
2022	771	7,837	$1,079,445
2023	867	8,370	$1,745,606
2024	877	8,884	$2,125,029

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	45	$3,369
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	28	$1,449
2022	N/R	16	$35,035
2023	N/R	24	$1,201
2024	N/R	26	$39,084

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	805	1,520	$92
78452	Nuclear medicine studies of heart muscle at rest and with stress and spect	667	671	$59
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	599	625	$53
93018	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician	247	249	$11
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	619	899	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Vyndamax	Tafamidis	14	960	$677,472
Eliquis	Apixaban	456	26,550	$503,844
Entresto	Sacubitril/Valsartan	128	7,118	$154,092
Xarelto	Rivaroxaban	95	6,330	$116,716
Repatha Sureclick	Evolocumab	75	4,436	$84,425

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
K0606	Automatic external defibrillator, with integrated electrocardiogram analysis, garment type	Y	N/R	15	$38,388
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	11	$696

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	156	$3,647	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christopher C. Oh, M.D.?

Tedicare shows public-source Medicare data for Christopher C. Oh, M.D. (NPI 1942208889), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher C. Oh, M.D. have ACO affiliation data?

Christopher C. Oh, M.D. is shown with ACO affiliation data for Aledade 91 CA MSSP Basic E (MSSP, ACO ID A5193).

What billing organization is linked to Christopher C. Oh, M.D.?

Christopher C. Oh, M.D. is linked to SVMHS CLINICS (billing NPI 1093158347) in the available physician profile data.

Does Christopher C. Oh, M.D. have Open Payments data?

Christopher C. Oh, M.D. has 156 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.